Ace Report Cover
No clear benefit of liposomal bupivacaine over plain bupivacaine for periarticular injection in TKA
Reprints
Cite This
Reprints
Cite This
AceReport Image
Arthroplasty
No clear benefit of liposomal bupivacaine over plain bupivacaine for periarticular injection in TKA
J Arthroplasty. 2018 Aug;33(8):2460-2464 doi: 10.1016/j.arth.2018.03.014

80 patients scheduled for total knee arthroplasty were randomized to periarticular infiltration analgesia completed using either liposomal bupivacaine or plain bupivacaine. Outcomes of interest included pain scores during physical therapy, narcotic consumption, and knee range of motion. Assessment timepoints included 24 hours, 48 hours, 72 hours, and at discharge. While pain scores during physical therapy were significantly lower in the liposomal bupivacaine group at 24 hours after surgery, the differences between groups at 48 hours after surgery and all other outcome measures were not statistically significant.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. No clear benefit of liposomal bupivacaine over plain bupivacaine for periarticular injection in TKA. ACE Report. 2018;8(10):23. Available from: https://myorthoevidence.com/AceReport/Report/no-clear-benefit-of-liposomal-bupivacaine-over-plain-bupivacaine-for-periarticular-injection-in-tka

Copy Citation
Share this Ace Report